<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Medicine (Baltimore)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Medicine (Baltimore)</journal-id>
      <journal-id journal-id-type="publisher-id">MEDI</journal-id>
      <journal-title-group>
        <journal-title>Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0025-7974</issn>
      <issn pub-type="epub">1536-5964</issn>
      <publisher>
        <publisher-name>Wolters Kluwer Health</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26962787</article-id>
      <article-id pub-id-type="pmc">4998868</article-id>
      <article-id pub-id-type="doi">10.1097/MD.0000000000002904</article-id>
      <article-id pub-id-type="art-access-id">02904</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>6200</subject>
        </subj-group>
        <subj-group>
          <subject>Research Article</subject>
          <subject>Clinical Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Burkitt-Type Acute Lymphoblastic Leukemia With Precursor B-Cell Immunophenotype and Partial Tetrasomy of 1q</article-title>
        <subtitle>A Case Report</subtitle>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Sato</surname>
            <given-names>Yuya</given-names>
          </name>
          <degrees>MD, PhD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kurosawa</surname>
            <given-names>Hidemitsu</given-names>
          </name>
          <degrees>MD, PhD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fukushima</surname>
            <given-names>Keitaro</given-names>
          </name>
          <degrees>MD, PhD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Okuya</surname>
            <given-names>Mayuko</given-names>
          </name>
          <degrees>MD, PhD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Arisaka</surname>
            <given-names>Osamu</given-names>
          </name>
          <degrees>MD, PhD</degrees>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Wu.</surname>
            <given-names>Yinyuan</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff>From the Department of Pediatrics, Dokkyo Medical University School of Medicine, Mibu, Tochigi, Japan.</aff>
      <author-notes>
        <corresp>Correspondence: Yuya Sato, Department of Pediatrics, Dokkyo Medical University, 880 Kita-Kobayashi, Mibu, Tochigi 321-0293, Japan (e-mail: <email>syuya@dokkyomed.ac.jp</email>).</corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <month>3</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>11</day>
        <month>3</month>
        <year>2016</year>
      </pub-date>
      <volume>95</volume>
      <issue>10</issue>
      <elocation-id>e2904</elocation-id>
      <history>
        <date date-type="received">
          <day>10</day>
          <month>11</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>14</day>
          <month>1</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>1</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2016 Wolters Kluwer Health, Inc. All rights reserved.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0">
          <license-p>This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link></license-p>
        </license>
      </permissions>
      <self-uri xlink:type="simple" xlink:href="medi-95-e02904.pdf"/>
      <abstract>
        <title>Abstract</title>
        <p>Burkitt-type acute lymphoblastic leukemia (B-ALL) is thought as a variant of Burkitt lymphoma/leukemia and derived from mature B-cell lymphoblast.</p>
        <p>B-ALL was developed in a 10-year-old girl. Two characteristics were apparent in this case. First, the lymphoblastic cells were positive for CD10, CD19, CD20, and CD22, but negative for terminal deoxynucleotidyl transferase and surface immunoglobulins, indicating a B-cell immunophenotype. The detection of t(8;14)(q24;q32) with a chromosomal analysis is required for a diagnosis of B-ALL. Second, der(1)(pter&#x200A;&#x2192;&#x200A;q32.1::q32.1&#x200A;&#x2192;&#x200A;q21.1::q11&#x200A;&#x2192;&#x200A;qter) was detected, in which 1q21.1 to 1q32.1 was inverted and inserted. Finally, partial tetrasomy of 1q was also present. Because B-ALL with abnormal chromosome 1 has been reported poor outcome, the usual chemotherapy for stage 4 Burkitt lymphoma with added rituximab was administered for our patient.</p>
        <p>We report B-ALL with precursor B-cell immunophenotype and interesting partial tetrasomy of 1q.</p>
      </abstract>
      <custom-meta-group>
        <custom-meta>
          <meta-name>OPEN-ACCESS</meta-name>
          <meta-value>TRUE</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Burkitt-type acute lymphoblastic leukemia (B-ALL) is classified as a variant of Burkitt lymphoma/leukemia. A combination of several diagnostic methods, including morphological, cytogenetic, and chromosomal analyses and immunophenotyping, is necessary to diagnose B-ALL with certainty.<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref></sup> B-ALL presents with a French&#x2013;American&#x2013;British (FAB) classification L3 morphology and a mature B-cell immunophenotype, with the surface expression of CD20 and surface immunoglobulins with clonally restricted light chains.<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref></sup> According to the 2008 World Health Organization (WHO) classification, a translocation involving <italic>MYC</italic>, t(8;14)(q24;q32), is highly characteristic of B-ALL, resulting in the constitutive expression of the <italic>MYC</italic> gene.<sup><xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R3" ref-type="bibr">3</xref></sup></p>
      <p>In a study by the Pediatric Oncology Group, B-ALL with a precursor B-cell immunophenotype was shown to occur in approximately 0.1% of children with ALL.<sup><xref rid="R4" ref-type="bibr">4</xref>&#x2013;<xref rid="R6" ref-type="bibr">6</xref></sup> Additional chromosomal aberrations can be present, with chromosomes 1, 6, 7, 13, 17, and 22 most commonly affected.<sup><xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R7" ref-type="bibr">7</xref></sup> We describe a case of B-ALL with a precursor B-cell immunophenotype and partial tetrasomy of 1q.</p>
      <sec sec-type="cases">
        <title>Case Report</title>
        <p>A 10-year-old girl was admitted to our hospital complaining of lassitude and fever. She displayed hepatosplenomegaly and pleural and abdominal effusions without lymphadenopathy. Lactate dehydrogenase (10,554&#x200A;U/L; normal range 106&#x2013;211&#x200A;U/L) was elevated. A peripheral blood examination showed the following counts: red blood cells 4.25&#x200A;&#xD7;&#x200A;10<sup>10</sup>/L, hemoglobin 11.8&#x200A;g/dL, hematocrit 36.2%, platelets 7.3&#x200A;&#xD7;&#x200A;10<sup>8</sup>/L, and white blood cells 4.4&#x200A;&#xD7;&#x200A;10<sup>7</sup>/L, and 48% of leukemic blasts had vacuoles in the cytoplasm (Figure <xref ref-type="fig" rid="F1">1</xref>A). Leukemic blasts accounted for 73.6% of the mononuclear bone-marrow cells. An immunophenotype analysis was positive for CD10, CD19, CD20, and CD22, and negative for terminal deoxynucleotidyl transferase and surface immunoglobulins, suggesting that the leukemic blasts had a precursor B-cell immunophenotype. A fluorescence in situ hybridization (FISH) analysis revealed an <italic>IgH/C-MYC</italic> gene fusion (Figure <xref ref-type="fig" rid="F1">1</xref>B). A G-band-staining chromosomal analysis revealed t(8;14) and an additional abnormality of chromosome 1. A spectral karyotyping FISH analysis and array-based comparative genomic hybridization (aCGH) were performed. A derivative chromosome 1 analysis revealed der(1)(pter&#x200A;&#x2192;&#x200A;q32.1::q32.1&#x200A;&#x2192;&#x200A;q21.1::q11&#x200A;&#x2192;&#x200A;qter), in which region 1q21.1 to 1q32.1 was inverted, inserted (Figure <xref ref-type="fig" rid="F2">2</xref>A&#x2013;C), and repeated 3 times, causing partial tetrasomy of 1q (Figure <xref ref-type="fig" rid="F2">2</xref>B and C). Another abnormality, t(2;4)(p13;q27), was also detected (Figure <xref ref-type="fig" rid="F2">2</xref>A). B-ALL with a precursor B-cell immunophenotype and 46,XY,t(8;14)(q24;q32),t(2;4)(p13;q27),der(1)(pter&#x200A;&#x2192;&#x200A;q32.1:: q32.1&#x200A;&#x2192;&#x200A;q21.1::q11&#x200A;&#x2192;&#x200A;qter) was diagnosed (Figure <xref ref-type="fig" rid="F2">2</xref>A&#x2013;C).</p>
        <fig id="F1" position="float">
          <label>FIGURE 1</label>
          <caption>
            <p>May&#x2013;Giemsa staining and fluorescent in situ hybridization analysis. (A) May&#x2013;Giemsa-staining-based morphological analysis revealed many cytoplasmic vacuoles but inconspicuous granules. The blasts were not typical of the FAB classification of L3. (B) Fluorescent in situ hybridization analysis using an <italic>IgH/C-MYC</italic> probe. The dual fusion translocation probe hybridized to the nucleus. The 3 yellow spots are <italic>IGH/C-MYC</italic> fusion gene signals.</p>
          </caption>
          <graphic xlink:href="medi-95-e02904-g001"/>
        </fig>
        <fig id="F2" position="float">
          <label>FIGURE 2</label>
          <caption>
            <p>G-band-staining-based chromosome analysis, spectral karyotyping fluorescent in situ hybridization (SKY-FISH) analysis, and array-based comparative genomic hybridization (aCGH) array. (A) G-band-stained chromosomes and SKY-FISH suggested 46XY and an additional abnormal karyotype involving t(8;14)(q24;q32), t(2;4)(p13;q27), and der(1)(pter&#x200A;&#x2192;&#x200A;q32.1::q32.1&#x200A;&#x2192;&#x200A;q21.1::q11&#x200A;&#x2192;&#x200A;qter). (B) aCGH array of chromosome 1 revealed partial gain of 1q21.1 to 1q32.1. This region conferred the partial tetrasomy of 1q. (C) Schema of chromosome 1.</p>
          </caption>
          <graphic xlink:href="medi-95-e02904-g002"/>
        </fig>
        <p>Dialysis was performed for tumor lysis syndrome before induction therapy was administered. Complete remission was achieved after B-precursor ALL induction therapy with prednisolone, vincristine, and doxorubicin. The consolidation therapy was adapted from a regimen for advanced Burkitt lymphoma, according to the Japan Pediatric Leukaemia/Lymphoma Study Group B-NHL 03 advanced-stage protocol, including 6 courses of prednisolone, vincristine, cyclophosphamide, methotrexate, pirarubicin, and etoposide. Rituximab was combined with the chemotherapy in last 2 courses. This patient has been in remission for 2 years.</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>B-ALL with a precursor B-cell immunophenotype has been shown to occur in approximately 0.1% of children with ALL, and a chromosomal analysis to detect t(8;14) is required for a correct diagnosis of B-ALL.<sup><xref rid="R1" ref-type="bibr">1</xref>&#x2013;<xref rid="R6" ref-type="bibr">6</xref></sup> Almost all patients suffering B-ALL with a precursor B-cell immunophenotype are administered induction therapy for B-cell ALL, and after a correct diagnosis is made, consolidation chemotherapy for B-ALL is commenced.<sup><xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R9" ref-type="bibr">9</xref></sup> It is unclear whether the progression of B-ALL with a precursor B-cell immunophenotype is worse than that of B-ALL, but because B-ALL is responds well to treatment, B-ALL with a precursor B-cell immunophenotype is expected to behave similarly.</p>
      <p>Chromosomal aberrations in addition to t(8;14) are often present in B-ALL, most commonly affecting chromosomes 1, 6, 7, 13, 17, and 22. The most frequent additional aberration involves the long arm of chromosome 1, typically as partial tetrasomy of 1q.<sup><xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R10" ref-type="bibr">10</xref></sup> The partial tetrasomy of 1q observed in our patient was caused by the inversion and insertion of chromosomal region 1q21.1 to 1q32.1 between 1q32.1 and 1q11. To the best of our knowledge, B-ALL with this partial tetrasomy of 1q, der(1)(pter&#x200A;&#x2192;&#x200A;q32.1:: q32.1&#x200A;&#x2192;&#x200A;q21.1::q11&#x200A;&#x2192;&#x200A;qter), has not previously been reported.</p>
      <p>Over 60% of the patients diagnosed with B-ALL and additional aberrations of chromosome 1 relapse or die.<sup><xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R10" ref-type="bibr">10</xref></sup> In our patient, the partial tetrasomy of 1q arose from the inversion of chromosomal region 1q21.1 to 1q32.1. The duplication of 1q21.1 has been reported in neuroblastoma,<sup><xref rid="R11" ref-type="bibr">11</xref></sup> and the development of familial nonmedullary thyroid cancer has been linked to the distribution of 1q21.1.<sup><xref rid="R12" ref-type="bibr">12</xref></sup> The wide variety of lymphomas associated with an abnormality of 1q21.1 has been also reported, including Burkitt lymphoma.<sup><xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R13" ref-type="bibr">13</xref>&#x2013;<xref rid="R20" ref-type="bibr">20</xref></sup> It is interesting that malignant neoplasms with 1q21.1 confer poor prognoses. These facts suggest that our patient also has a poor prognosis. However, the partial tetrasomy of 1q involved the chromosomal region from 1q21.1 to 1q32.1, which was not only inserted but also inverted in our patient. We also speculate that the inverted chromosomal region 1q21.1 to 1q32.1 may act as an antisense molecule. The antisense molecule may induce different prognosis compared with malignant neoplasms with 1q21.1.</p>
      <p>Based on our hypothesis and the fact that B-ALL with more than 3 cytogenetic abnormalities confers a poor prognosis,<sup><xref rid="R7" ref-type="bibr">7</xref></sup> rituximab was added to the consolidation therapy for B-ALL in our patient to ensure a good outcome.<sup><xref rid="R21" ref-type="bibr">21</xref></sup> The patients have been in complete remission for 3 years since chemotherapy. We also think that stem-cell transplantation would be an effective intervention, but has not been available to our patient because no human leukocyte antigen (HLA)-matched donor has been found.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgment</title>
      <p>We are grateful for the help of Dr. Toshiyuki Yamamoto, Graduate of Medicine at Tokyo Women's Medical University, for the array-based comparative genomic hybridization analysis.</p>
    </ack>
    <fn-group>
      <fn fn-type="abbr">
        <p>Abbreviations: aCGH = array-based comparative genomic hybridization, B-ALL = Burkitt-type acute lymphoblastic leukemia, FAB = French&#x2013;American&#x2013;British, FISH = fluorescence in situ hybridization, HLA = human leukocyte antigen, WHO = World Health Organization</p>
      </fn>
      <fn fn-type="other">
        <p>Consent: The patient and his parents gave their informed consent for the publication of this case report and accompanying images. Ethical approval for this study was waived by the Ethics Committee of Dokkyo Medical University because the study is a single case report.</p>
      </fn>
      <fn fn-type="COI-statement">
        <p>The authors have no conflicts of interest to disclose.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="R1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellan</surname><given-names>C</given-names></name><name><surname>Stefano</surname><given-names>L</given-names></name><name><surname>Giulia de</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach</article-title>. <source><italic>Hematol Oncol</italic></source>
<year>2010</year>; <volume>28</volume>:<fpage>53</fpage>&#x2013;<lpage>56</lpage>.<pub-id pub-id-type="pmid">19844983</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roug</surname><given-names>AS</given-names></name><name><surname>Wendtland</surname><given-names>P</given-names></name><name><surname>Bendix</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Supernumerary isochromosome 1, idic(1)(p12), leading to tetrasomy 1q in Burkitt lymphoma</article-title>. <source><italic>Cytogenet Genome Res</italic></source>
<year>2014</year>; <volume>142</volume>:<fpage>7</fpage>&#x2013;<lpage>13</lpage>.<pub-id pub-id-type="pmid">24217199</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campo</surname><given-names>E</given-names></name><name><surname>Swerdlow</surname><given-names>SH</given-names></name><name><surname>Harris</surname><given-names>NL</given-names></name><etal/></person-group>
<article-title>The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications</article-title>. <source><italic>Blood</italic></source>
<year>2011</year>; <volume>117</volume>:<fpage>5019</fpage>&#x2013;<lpage>5032</lpage>.<pub-id pub-id-type="pmid">21300984</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navid</surname><given-names>F</given-names></name><name><surname>Mosijczuk</surname><given-names>AD</given-names></name><name><surname>Head</surname><given-names>DR</given-names></name><etal/></person-group>
<article-title>Acute lymphoblastic leukemia with the (8;14)(q24;q32) translocation and FAB L3 morphology associated with a B-precursor immunophenotype: the Pediatric Oncology Group experience</article-title>. <source><italic>Leukemia</italic></source>
<year>1999</year>; <volume>13</volume>:<fpage>135</fpage>&#x2013;<lpage>141</lpage>.<pub-id pub-id-type="pmid">10049049</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komrokji</surname><given-names>R</given-names></name><name><surname>Lancet</surname><given-names>J</given-names></name><name><surname>Felgar</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Burkitt's leukemia with precursor B-cell immunophenotype and atypical morphology (atypical Burkitt's leukemia/lymphoma): case report and review of literature</article-title>. <source><italic>Leuk Res</italic></source>
<year>2003</year>; <volume>27</volume>:<fpage>561</fpage>&#x2013;<lpage>566</lpage>.<pub-id pub-id-type="pmid">12648517</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>AA</given-names></name><name><surname>Grant</surname><given-names>R</given-names></name><name><surname>Shago</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Occurrence of t(8;22)(q24.1;q11.2) involving the MYC locus in a case of pediatric acute lymphoblastic leukemia with a precursor B cell immunophenotype</article-title>. <source><italic>J Pediatr Hematol Oncol</italic></source>
<year>2004</year>; <volume>26</volume>:<fpage>532</fpage>&#x2013;<lpage>534</lpage>.<pub-id pub-id-type="pmid">15284595</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poirel</surname><given-names>H</given-names></name><name><surname>Cairo</surname><given-names>M</given-names></name><name><surname>Heerema</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study</article-title>. <source><italic>Leukemia</italic></source>
<year>2009</year>; <volume>23</volume>:<fpage>323</fpage>&#x2013;<lpage>331</lpage>.<pub-id pub-id-type="pmid">19020548</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirzel</surname><given-names>AC</given-names></name><name><surname>Cotrell</surname><given-names>A</given-names></name><name><surname>Gasparini</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Precursor B-Cell Acute Lymphoblastic Leukemia/Lymphoma with L3 Morphology, Philadelphia Chromosome, MYC Gene Translocation, and Coexpression of TdT and Surface Light Chains: a case report</article-title>. <source><italic>Case Rep Pathol</italic></source>
<year>2013</year>; <volume>2013</volume>:<fpage>679892</fpage>.<pub-id pub-id-type="pmid">23533894</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rawlinson</surname><given-names>NJ</given-names></name><name><surname>Baker</surname><given-names>P</given-names></name><name><surname>Kahwash</surname><given-names>SB</given-names></name></person-group>
<article-title>Burkitt's leukemia with an atypical immunophenotype: report of a case and review of literature</article-title>. <source><italic>Lab Hematol</italic></source>
<year>2011</year>; <volume>17</volume>:<fpage>27</fpage>&#x2013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">22189212</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#xED;a</surname><given-names>JL</given-names></name><name><surname>Hernandez</surname><given-names>JM</given-names></name><name><surname>Guti&#xE9;rrez</surname><given-names>NC</given-names></name><etal/></person-group>
<article-title>Abnormalities on 1q and 7q are associated with poor outcome in sporadic Burkitt's lymphoma. A cytogenetic and comparative genomic hybridization study</article-title>. <source><italic>Leukemia</italic></source>
<year>2003</year>; <volume>17</volume>:<fpage>2016</fpage>&#x2013;<lpage>2024</lpage>.<pub-id pub-id-type="pmid">14513052</pub-id></mixed-citation>
      </ref>
      <ref id="R11">
        <label>11.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diskin</surname><given-names>SJ</given-names></name><name><surname>Hou</surname><given-names>C</given-names></name><name><surname>Glessner</surname><given-names>JT</given-names></name><etal/></person-group>
<article-title>Copy number variation at 1q21.1 associated with neuroblastoma</article-title>. <source><italic>Nature</italic></source>
<year>2009</year>; <volume>459</volume>:<fpage>987</fpage>&#x2013;<lpage>991</lpage>.<pub-id pub-id-type="pmid">19536264</pub-id></mixed-citation>
      </ref>
      <ref id="R12">
        <label>12.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suh</surname><given-names>I</given-names></name><name><surname>Filetti</surname><given-names>S</given-names></name><name><surname>Vriens</surname><given-names>MR</given-names></name><etal/></person-group>
<article-title>Distinct loci on chromosome 1q21 and 6q22 predispose to familial nonmedullary thyroid cancer: a SNP array-based linkage analysis of 38 families</article-title>. <source><italic>Surgery</italic></source>
<year>2009</year>; <volume>146</volume>:<fpage>1073</fpage>&#x2013;<lpage>1080</lpage>.<pub-id pub-id-type="pmid">19958934</pub-id></mixed-citation>
      </ref>
      <ref id="R13">
        <label>13.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiffman</surname><given-names>JD</given-names></name><name><surname>Lorimer</surname><given-names>PD</given-names></name><name><surname>Rodic</surname><given-names>V</given-names></name><etal/></person-group>
<article-title>Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin-fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expression</article-title>. <source><italic>Br J Haematol</italic></source>
<year>2011</year>; <volume>155</volume>:<fpage>477</fpage>&#x2013;<lpage>486</lpage>.<pub-id pub-id-type="pmid">21981616</pub-id></mixed-citation>
      </ref>
      <ref id="R14">
        <label>14.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakashima</surname><given-names>Y</given-names></name><name><surname>Tagawa</surname><given-names>H</given-names></name><name><surname>Suzuki</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type</article-title>. <source><italic>Genes Chromosomes Cancer</italic></source>
<year>2005</year>; <volume>44</volume>:<fpage>247</fpage>&#x2013;<lpage>255</lpage>.<pub-id pub-id-type="pmid">16049916</pub-id></mixed-citation>
      </ref>
      <ref id="R15">
        <label>15.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Youssif</surname><given-names>C</given-names></name><name><surname>Goldenbogen</surname><given-names>J</given-names></name><name><surname>Hamoudi</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Genomic profiling of pediatric ALK-positive anaplastic large cell lymphoma: a Children's Cancer and Leukaemia Group Study</article-title>. <source><italic>Genes Chromosomes Cancer</italic></source>
<year>2009</year>; <volume>48</volume>:<fpage>1018</fpage>&#x2013;<lpage>1026</lpage>.<pub-id pub-id-type="pmid">19691112</pub-id></mixed-citation>
      </ref>
      <ref id="R16">
        <label>16.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Leeuw</surname><given-names>RJ</given-names></name><name><surname>Davies</surname><given-names>JJ</given-names></name><name><surname>Rosenwald</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes</article-title>. <source><italic>Hum Mol Genet</italic></source>
<year>2004</year>; <volume>13</volume>:<fpage>1827</fpage>&#x2013;<lpage>1837</lpage>.<pub-id pub-id-type="pmid">15229187</pub-id></mixed-citation>
      </ref>
      <ref id="R17">
        <label>17.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willis</surname><given-names>TG</given-names></name><name><surname>Zalcberg</surname><given-names>IR</given-names></name><name><surname>Coignet</surname><given-names>LJ</given-names></name><etal/></person-group>
<article-title>Molecular cloning of translocation t(1;14)(q21;q32) defines a novel gene (BCL9) at chromosome 1q21</article-title>. <source><italic>Blood</italic></source>
<year>1998</year>; <volume>91</volume>:<fpage>1873</fpage>&#x2013;<lpage>1881</lpage>.<pub-id pub-id-type="pmid">9490669</pub-id></mixed-citation>
      </ref>
      <ref id="R18">
        <label>18.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karnan</surname><given-names>S</given-names></name><name><surname>Tagawa</surname><given-names>H</given-names></name><name><surname>Suzuki</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Analysis of chromosomal imbalances in de novo CD5-positive diffuse large-B-cell lymphoma detected by comparative genomic hybridization</article-title>. <source><italic>Genes Chromosomes Cancer</italic></source>
<year>2004</year>; <volume>39</volume>:<fpage>77</fpage>&#x2013;<lpage>81</lpage>.<pub-id pub-id-type="pmid">14603444</pub-id></mixed-citation>
      </ref>
      <ref id="R19">
        <label>19.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lestou</surname><given-names>VS</given-names></name><name><surname>Ludkovski</surname><given-names>O</given-names></name><name><surname>Connors</surname><given-names>JM</given-names></name><etal/></person-group>
<article-title>Characterization of the recurrent translocation t (1; 1)(p36.3; q21.1-2) in non-Hodgkin lymphoma by multicolor banding and fluorescence in situ hybridization analysis</article-title>. <source><italic>Genes Chromosomes Cancer</italic></source>
<year>2003</year>; <volume>36</volume>:<fpage>375</fpage>&#x2013;<lpage>381</lpage>.<pub-id pub-id-type="pmid">12619161</pub-id></mixed-citation>
      </ref>
      <ref id="R20">
        <label>20.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tagawa</surname><given-names>H</given-names></name><name><surname>Suguro</surname><given-names>M</given-names></name><name><surname>Tsuzuki</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma</article-title>. <source><italic>Blood</italic></source>
<year>2005</year>; <volume>106</volume>:<fpage>1770</fpage>&#x2013;<lpage>1777</lpage>.<pub-id pub-id-type="pmid">15886317</pub-id></mixed-citation>
      </ref>
      <ref id="R21">
        <label>21.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malbora</surname><given-names>B</given-names></name><name><surname>Avci</surname><given-names>Z</given-names></name><name><surname>Olgac</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Successful treatment of ICE-rituximab chemotherapy and subsequent bone marrow transplantation in a patient with early-relapse Burkitt leukemia and inverted duplication of 1q</article-title>. <source><italic>J Pediatr Hematol Oncol</italic></source>
<year>2012</year>; <volume>34</volume>:<fpage>e84</fpage>&#x2013;<lpage>e85</lpage>.<pub-id pub-id-type="pmid">22258345</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
